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ABSTRACT
Purpose To determine whether formulations containing
ceramides (including a ceramide with a long hydroxyl acyl
chain linked to a linoleate, CER EOS) and fatty acids are able
to repair the skin barrier by normalizing the lipid organization
in stratum corneum (SC).
Methods The formulations were applied on a skin barrier
repair model consisting of ex vivo human skin from which SC
was removed by stripping. The effect of formulations on the
lipid organization and conformational ordering in the regen-
erated SC were analyzed using Fourier transform infrared
spectroscopy and small angle X-ray diffraction.
Results Application of the formulation containing only one
ceramide on regenerating SC resulted in a higher fraction of
lipids adopting an orthorhombic organization. A similar frac-
tion of lipids forming an orthorhombic organization was ob-
served after application of a formulation containing two
ceramides and a fatty acid on regenerating SC. No effects
on the lamellar lipid organization were observed.
Conclusions Application of a formulation containing either a
single ceramide or two ceramides and a fatty acid on
regenerating SC, resulted in a denser lateral lipid packing of
the SC lipids in compromised skin. The strongest effect was
observed after application of a formulation containing a single
ceramide.
KEY WORDS Ceramides . lipid organization . skin barrier
repair . topical formulation
ABBREVIATIONS
AD Atopic dermatitis
CER Ceramide
CHOL Cholesterol
FA Fatty acid
FormBasic Basic formulation without CERs
FormCOMBI Formulation with CER EOS, CER NS, and
FA22
FormEOS Formulation with CER EOS
Form(d)NS Formulation with (deuterated) CER NS
FTIR Fourier transform infrared spectroscopy
LPP Long periodicity phase
SAXD Small angle X-ray diffraction
SC Stratum corneum
SkinBaR Skin barrier repair
SPP Short periodicity phase
TEWL Transepidermal water loss
VC Vernix caseosa
INTRODUCTION
One of the major roles of the skin is its protection against
penetration of irritants, pathogens, and allergens, and pre-
vention of excessive transepidermal water loss (TEWL)
avoiding desiccation of the body. The skin barrier function
is located in the uppermost epidermal layer, namely the
stratum corneum (SC). SC consists of terminally differenti-
ated corneocytes embedded in a lipid matrix. The main
lipid classes present in the matrix are ceramides (CERs),
fatty acids (FAs), and cholesterol (CHOL). This lipid matrix
is important for a proper skin barrier function (1). The
intercellular lipids are assembled in two lamellar phases,
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with a repeat distance of either 13 nm or 6 nm, referred to
as the long periodicity phase (LPP) and the short periodicity
phase (SPP), respectively (2–6). Within these lamellar
sheets, in healthy skin the lipids are mainly packed in an
orthorhombic packing, while a small fraction of lipids
adopts a hexagonal packing (Fig. 1) (7–10). In several in-
flammatory skin diseases, a higher fraction of the intercel-
lular lipids assembles in a hexagonal packing, such as in
atopic dermatitis (AD) (11). This less dense lipid organiza-
tion is associated with a reduction in lipid chain length in
SC of AD patients and a reduced skin barrier function
(11–14). As the lipids play a role in the reduced skin barrier,
normalization of the lipid composition and organization
may improve the skin barrier function. Normalization of
the lipid organization may be achieved by topical applica-
tion of lipid formulations.
Previously, topical formulations based on vernix caseosa
(VC) were developed. VC is a white cream that is developed
on the fetal skin during the last trimester of pregnancy. It
serves as a lubricant during delivery and it protects the new-
born’s skin from dehydration (15). VC contains barrier lipids
CERs, FAs, and CHOL, but also other lipids such as super
sterol esters, wax esters, squalene, and triglycerides. VC en-
hances skin barrier repair in mice (16,17).
In order to select the most effective formulation for skin
barrier repair, studies are required in which the composi-
tions of the formulations need to be altered in a systematic
way. When performing these studies in vivo, multiple clinical
studies and/or animal studies will be needed. This is very
challenging as in clinical studies only a limited number of
formulations can be investigated. Furthermore, animal skin
is very different from human skin (18). Therefore, we de-
veloped an ex vivo skin barrier repair (SkinBaR) model (19).
In this model, the SC is removed by stripping and subse-
quently regenerated during an 8-day culturing period. The
regenerated SC of the SkinBaR model shows several fea-
tures that are also observed in SC of AD patients, e.g. a
higher fraction of lipids adopting a hexagonal lateral lipid
organization and a CER profile that mimics the altered
CER subclass composition in AD skin in several aspects
(19). Using this model, the influence of topical formulations
on the lipid organization and composition of the SC can be
examined in in vitro settings.
In this study, we used the SkinBaR model to examine
whether two CERs of a VC based formulation remain on
top of the SC, or are incorporated in the lipid matrix of the
SC during repair, thereby improving the lipid organization.
We used protiated and partially deuterated CERs. One
CER subclass had a very long esterified ω-hydroxy acyl
chain (Fig. 1), referred to as CER EOS. The VC based
formulation contains a basic formulation (FormBasic) and ei-
ther a single CER subclass or both CER subclasses in com-
bination with a FA. After regeneration of SC, the organiza-
tion of the lipids in the matrix was examined. Our results
Fig. 1 Lipid organization in the SC. (a) Schematic overview of the skin morphology, (b) The corneocytes are embedded in the lipid matrix in a brick and mortar
structure, (c) The lipids in the matrix are stacked in lamellae in between the corneocytes, (d) Detail of the lipid lamellae, (e) Perpendicular to the lamellae, the
lipids are organized in a lateral packing. This can be either orthorhombic, hexagonal, or liquid (from left to right), (f) The lipid lamellae are stacked on top of each
other with a repeat distance (d) of either 13 nm (LPP) or 6 nm (SPP), (g)Molecular structure and nomenclature of the two CER subclasses used in these studies.
The sphingoid base is depicted in blue, and the acyl chain in black.
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demonstrate that the applied formulations containing a sin-
gle ceramide are able to enhance the formation of an ortho-
rhombic lateral packing and are, at least partly, incorporated
in the SC lipid matrix.
MATERIAL AND METHODS
Composition and Preparation of Formulations
Two subclasses of synthetic CER were used in these studies
(Fig. 1). One CER subclass was the esterified ω-hydroxy
acyl chain with 30 carbon atoms in the acyl chain linked
to a sphingosine base (18 carbon atoms), referred to as CER
EOS according to the classification of Motta et al. (20). The
other CER was composed of a non-hydroxy acyl chain of
24 carbon atoms linked to a sphingosine base (18 carbon
atoms), referred to as CER NS. Deuterated CER NS
(dCER NS) consists of a perdeuterated acyl chain and a
protiated base.
The basic formulation (FormBasic) contained a mixture of
super sterol esters, triglycerides (Miglyol 812), squalene, and
CHOL in a weight ratio of 13.6:10.1:1.8:1. This basic mix-
ture is supplemented with either CER EOS, CER NS, or
dCER NS. For the exact compositions of the formulations
and the used abbreviations throughout this paper, see
Table I. The use of dCER NS offers the opportunity to
selectively detect the deuterated acyl chain of CER NS as
CD2 vibrations in the infrared spectrum are shifted to lower
wavenumbers compared to their protiated counterparts (also
see below). In addition to the single CER component in the
formulation, a formulation with both CER EOS and CER
NS as well as a FA with a chain length of 22 carbon atoms
(behenic acid; referred to as FA22) was prepared. Three
variations of this formulation were made: i) all lipids were
protiated, ii) dCER NS was used instead of CER NS, iii)
dFA22 (perdeuterated chain) was used instead of FA22 (see
Table I). Finally, the basic formulation (FormBasic) without
CER or FA was examined.
The formulations were prepared by dissolving the lipids in
either chloroform:methanol (2:1, used for CHOL, CERs, and
FA22), chloroform (super sterol esters), or acetone (squalene).
Triglycerides were used undissolved. In total 100 mg of the
dissolved lipids and triglycerides were mixed in the required
ratio in a small glass vial and left to dry under a stream of
nitrogen at 40°C for approximately 3 h. In order to distribute
the lipids homogeneously in the formulation, the dried lipid
mixture was transferred to a mixing tube modified for small
scale purposes and mixed for 5 min at 500 rpm using a mod-
ified automatic ointment-mixer TopiTec® (WEPA,
Germany) (17,21).
Preparation and Culturing of Ex Vivo Skin
Human skin was obtained after surgery from a local hospital
according to principles of the Declaration of Helsinki, and
used within 12 h after surgery. Stripping and culturing proce-
dures are described in the supplementary material.
Formulations were applied in a single dose of about 5 mg/
cm2 in a metal ring placed on top of the skin at day 0 of the
culturing period by rotating movements with the back of a
small metal vial (ø = 15 mm) which was covered with one of
the formulations (see Table I).
Subsequently, the skin was cultured for 8 days in an incu-
bator during which the SC regenerated. The incubator con-
ditions were 37°C, 90% relative humidity, and 7.2% CO2.
The culture medium was refreshed twice a week. The com-
position of the medium has been described in Danso et al. (19).
Studies were performed at least in triplicate using the fol-
lowing conditions:
i) Stripped and cultured skin
ii) Stripped and cultured skin + FormBasic
iii) Stripped and cultured skin + FormEOS
iv) Stripped and cultured skin + FormNS or FormdNS
v) Str ipped and cul tured sk in + FormCOMBI ,
FormCOMBI(dNS) or FormCOMBI(dFA)
Human skin from the same donor served as control.
After culturing, the skin was harvested and either embed-
ded in paraffin, or SC was isolated (see supplementary
material). Isolated SC samples were used to examine the lipid
Table I The Names and
Composition of the Various
Formulations Used in this Study.
Numbers Represent the Weight
Percentage of the Components
Name Basic mixture CER EOS CER NS dCER NS FA22 dFA22
FormBasic 100
FormEOS 98 2
FormNS 98 2
FormdNS 95 5
FormCOMBI 94.5 2 2 1.5
FormCOMBI(dNS) 94.5 2 2 1.5
FormCOMBI(dFA) 94.5 2 2 1.5
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organization or conformational ordering using either Fourier
transform infrared spectroscopy (FTIR) or small angle X-ray
diffraction (SAXD). Both methods are described in the sup-
plementary material. FTIR provides information about the
lateral packing and conformational ordering, while SAXD is
used to obtain information about the lamellar organization.
Statistical Analysis
T-test and one-way ANOVA with a multiple comparisons
post hoc test were used to analyze the data using GraphPad
prism 7 software (GraphPad software Inc., San Diego, CA,
USA).
RESULTS
Formulations Do Not Influence the Morphology
of Cultured Skin
As can be observed in Fig. 2, after culturing for 8 days, the
epidermis of the stripped and cultured skin was slightly thicker
than in native skin and the basal layer was less compact. The
morphology of the stripped and cultured skin on which
FormEOS, FormNS, and FormCOMBI were applied was com-
parable to the stripped and cultured skin without formulation.
This indicates a viable epidermis after 8 days of culturing, also
in the presence of a formulation.
Ceramides Do Not Influence Lateral Organization
of Formulation
CH2 rocking vibrations in the FTIR spectra were analyzed in
order to examine the lateral lipid organization. When lipids
are assembled in a hexagonal packing, only one vibration at
around 719 cm−1 is visible in the FTIR spectrum. When the
lipids adopt a more dense orthorhombic lateral packing,
short-range coupling occurs due to interactions of adjacent
protiated chains which results in a splitting of the contours.
In this case, two peaks are visible at around 719 and 730 cm−1.
Deuterated chains participating in the same lattice as the
protiated lipid chains interfere with the vibrations of the
protiated chains, thereby reducing the short-range coupling.
This is visible as a reduction in intensity or disappearance of
the peak positioned at 730 cm−1. In order to be able to com-
pare the intensity of the peaks, all spectra are displayed with a
similar ratio between the lowest point at around 715 cm−1 and
the top at around 719 cm−1.
First the spectra of the formulations will be reported. CH2
rocking vibrations of FormEOS, FormNS, and FormdNS
showed a strong peak positioned at 719 and a weak peak at
730 cm−1, indicating that a small fraction of lipids forms an
orthorhombic lateral organization. Furthermore, a third peak
was observed at a wavenumber of about 723 cm−1 (Fig. 3a-c).
This peak can be attributed to the presence of the triglycer-
ides, which showed a single peak of the CH2 rocking vibra-
tions at a wavenumber of about 723 cm−1 (Fig. 3d). No dif-
ferences were observed between the various formulations be-
low 10°C. The contour at 730 cm−1 in all formulations started
Fig. 2 Morphology was examined
using HE staining. (a)Native human
skin, (b) Skin with stripped and
cultured SC, (c) Stripped and
cultured skin on which FormEOS
was applied, (d) Stripped and
cultured skin on which FormNS was
applied, (e) Stripped and cultured
skin on which FormCOMBI was
applied. Scale bar: 50 μm.
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to decrease at a temperature of around 10°C and disappeared
at 28°C in FormEOS and at 22°C in FormNS and FormdNS.
This transition is indicative for the disappearance of the or-
thorhombic lateral packing. Above this temperature all for-
mulation showed similar FTIR profiles. When analyzing
FormBasic (no barrier lipids present), the FTIR profile was
characterized by a doublet of which the peak at a wavenum-
ber of 730 cm−1 disappeared between 10 and 28°C (results
not shown).
The profile of pure CER NS was characterized by a single
peak located at around 719 cm−1, whereas for pure CER
EOS a doublet at around 719 and 730 cm−1 was observed
which was still weakly present at 60°C (Supplementary
Figure 1). However, both CER containing formulations and
the control formulation showed a similar profile until 10°C,
indicating that the CERs do not influence the lateral packing
of the formulation at low temperatures as far as it can be
detected by FTIR.
Conformational Ordering of the Lipids is Not Affected
by Ceramides in the Formulation
The conformational ordering of the lipids was analyzed
in order to examine the ordered-disordered phase
transition of the lipids in the formulations. This was
determined by assessing the thermotropic behavior of
CH2 symmetric and CD2 asymmetric stretching vibra-
tions in the FTIR spectrum. When lipids show a high
conformational ordering, indicating that the chains are
fully extended, CH2 and CD2 stretching vibration peaks
are positioned below a wavenumber of 2850 and
2195 cm−1, respectively. Peak positions increase to
wavenumbers above 2852 and 2196 cm−1, respectively,
when the lipids have a high conformational disordering,
indicating the presence of a liquid phase. Peak positions
of CH2 symmetric and CD2 asymmetric stretching vi-
brations of the formulations are plotted against temper-
ature (Fig. 4). The onset transition temperature was de-
termined as described in the supplementary methods
section. Figure 4a shows the temperature dependence
of FormBasic, FormEOS, and FormNS, which are very
similar. At 0°C, the peak positions were located at a
wavenumber of around 2849 cm−1, indicating an or-
dered lateral lipid organization. The onset transition
temperatures of the ordered-disordered transition of
the formulations were approximately 9–10°C. At these
temperatures, the CH2 symmetric stretching vibrations
started to shift to a wavenumber of around 2853 cm−1
at 20°C. These increases in wavenumber were steep,
representing an ordered-disordered transition. During a
further rise in temperature, the CH2 stretching vibra-
tions increased gradually until about 2855 cm−1 at
90°C. Furthermore, a small shift in wavenumber was
observed in the profiles of FormEOS and FormNS at
around 50–60°C (see inset). This might be attributed
to a change in conformational ordering of CER EOS
and CER NS in the formulation (see below).
The temperature dependence of the CD2 stretching vibra-
tions of the deuterated acyl chain of pure dCER NS and in
FormdNS is depicted in Fig. 4b. At 0°C, the CD2 asymmetric
stretching peak positions of both FormdNS and pure dCER NS
were located at 2194 cm−1. The onset transition temperatures
were 53°C for FormdNS and 91°C for pure dCERNS. At these
temperatures sharp increases in wavenumbers were observed
until a wavenumber of around 2197 cm−1 was reached at 64°C
and 100°C, respectively. The onset transition temperature of
pure dCER NS was substantially higher than that of FormdNS,
indicating that dCERNS interacts with the lipids in the formu-
lation. However, the temperature of transition is not similar to
that of the protiated chains indicating that dCER NS is not
homogenously mixing with the other protiated components.
Influence of Topical Formulation on Lateral Lipid
Organization of Regenerated SC
The CH2 rocking vibrations in the FTIR spectrum of native
SC showed two strong peaks positioned at 719 and 730 cm−1
Fig. 3 FTIR spectra showing CH2 rocking vibrations of lipids in formulations
as a function of temperature (0–60°C) (a) FormEOS, (b) FormNS, (c)
FormdNS, and (d) Triglycerides.
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(Supplementary Fig. 2), indicative for an orthorhombic lateral
packing of the lipids. Figure 5a displays CH2 rocking vibra-
tions in the FTIR spectra of regenerated SC, which showed a
contour with a strong intensity at around 719 cm−1 and a peak
with a weak intensity at around 730 cm−1. This indicates that
a higher fraction of lipids adopted a hexagonal lateral packing
compared to native SC.
The formulations were applied on the SkinBaR mod-
el in order to examine if the CERs from the formula-
tions are incorporated in the SC lipid matrix and fur-
thermore if they participate in the same lattice as SC
lipids. After FormEOS was applied during SC regenera-
tion, the peak at 730 cm−1 had a stronger intensity
(relative to the intensity of the 719 cm−1 peak) than
that in the spectrum of regenerated SC, indicating a
higher level of lipids adopting an orthorhombic lateral
packing. After application of FormNS during regenera-
tion of SC, the relative intensity of the peak at
730 cm−1 was slightly lower than after application of
FormEOS, but higher than in the spectrum of the un-
treated stripped and regenerated SC. A gradual de-
crease of the peaks around 730 cm−1 occurred between
12 and 32°C (regenerated SC), 20°C and 36°C (appli-
cation of FormEOS), and 12°C and 24°C (application of
FormNS). This indicates that the orthorhombic to hex-
agonal phase transition took place at lower temperatures
than in native SC, but that the presence of CER EOS
increased the transition temperature slightly.
The next question is whether CERs from the topically ap-
plied formulation form separate domains in the lipidmatrix or
that these CERs are partitioning in the same lattice as SC
lipids. In order to examine this, CH2 rocking vibrations were
examined after topical application of FormdNS (Fig. 5d). The
relative intensity of the peak located at 730 cm−1 was similar
to the relative intensity of the peak visible after application of
its protiated counterpart. This indicates that dCER NS does
not partition in the orthorhombic domains. To examine the
possibility that CER NS interacts with the hexagonal lateral
domains, the temperature dependence of the lateral ordering
of the lipids was examined.
Fig. 5 FTIR spectra showing CH2 rocking vibrations of SC lipids with and
without topical application of formulation as a function of temperature (0–
60°C). (a) regenerated SC, (b) regenerated SC with topical application of
FormEOS, (c) regenerated SC with topical application of FormNS, (d) regen-
erated SC with topical application of Form.dNS
Fig. 4 Peak positions of CH2 symmetric stretching vibrations and CD2 asymmetric stretching vibrations of FTIR spectra plotted as a function of temperature (0–
90°C). (a) CH2 symmetric stretching vibrations of Form
Basic, FormEOS, and FormNS. (b) Asymmetric CD2 stretching vibrations of the deuterated acyl chain of
dCER NS and in Form.dNS
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Similar Ordering of Lipids in Regenerated SC
in Presence or Absence of a Formulation
When monitoring the CH2 symmetric stretching vibrations of
native, regenerated SC, and regenerated SC after application
of formulations, very similar temperature dependence was ob-
served (Fig. 6a). A small shift in vibration frequency from 2849
to 2850 cm−1 at around 30–40°C was observed in the spectra
of native and regenerated SC, which is attributed to the or-
thorhombic to hexagonal phase transition. The start of the
ordered-disordered phase transitions were observed at tem-
peratures of 69.3°C± 4.0 (n = 6) for native SC and 64°C ±
1.5 (n = 7) for regenerated SC. The onset transition tempera-
ture after application of FormEOS was not affected compared
to regenerated SC (62.8°C ± 2.0, p = 0.99 (n = 3)), whereas
after application of FormNS the onset transition temperature
was significantly lowered to 58.0°C± 3.6 (p = 0.02 (n = 3)).
Figure 6b depicts the temperature dependence of CD2
asymmetric stretching vibrations of regenerated SC on which
FormdNS was applied. A gradual increase in wavenumber was
observed between 0 and 50°C. The onset transition tempera-
ture was 56°C and the end of the transition occurred at
71.0°C± 1.9. This is a significantly higher temperature than
for only FormdNS, which was 62.2°C (Fig. 4b, p=0.03). This
difference in temperature indicates that there is interaction
between dCER NS from the formulation and the SC lipid
matrix.
Combining CER and FA in the Formulation
The final studies focused on a formulation in which both CER
EOS and CER NS were included, as well as FA22
(FormCOMBI). First, the formulation was stored for a period
of 6 months at room temperature during which the physical
stability was examined at regular time intervals. Polarization
microscopy and wide and small angle X-ray diffraction
(WAXD and SAXD) were used to examine the physical sta-
bility. No crystals were observed in the microscopy images
during and after 6 months of storage (results not shown).
However, some “Maltese cross” were observed using polari-
zation microscopy, which are indicative for lamellar struc-
tures. Additionally, diffraction patterns confirmed the pres-
ence of lamellar structures and showed that a fraction of lipids
in the formulation adopted an orthorhombic lateral packing
at room temperature. No additional peaks were observed,
indicating that no crystals were present in the formulation
(results not shown).
The lateral lipid organization of FormCOMBI with only
protiated lipids was examined using FTIR (Fig. 7a). The con-
tour at 730 cm−1 disappeared in the same temperature range
as in FormEOS and FormNS. However, the relative intensity of
the contour at 730 cm−1 was higher compared to a formula-
tion with only one CER subclass, indicating that a higher
fraction of lipids adopted an orthorhombic lateral packing in
FormCOMBI.
When substituting CER NS by dCER NS (Fig. 7b) or
FA22 by dFA22 (Fig. 7c) in the formulation, the relative in-
tensity of the peak at 730 cm−1 was reduced compared to the
formulation with only protiated lipids. This suggests that a
fraction of the deuterated lipids partitions in the orthorhombic
lattice formed by the protiated lipids of the formulation (see
above).
The thermotropic behavior of the CH2 stretching vibration
in the spectrum of FormCOMBI with only protiated lipids was
highly comparable to the formulations with only one CER.
However, the onset transition temperature was increased to
16°C (Fig. 7d). When replacing FA22 by dFA22 the onset
transition temperature of the CD2 asymmetric stretching vi-
brations was at 18°C and took place over a large temperature
range, indicating an order-disorder transition over a large
temperature interval. The onset transition temperature was
somewhat higher than the formulation with protiated lipids,
but lower than the onset transition temperatures of pure
dFA22 (22). When substituting CER NS by dCER NS, the
onset transition temperature was 55°C (Fig. 7e), which is also
substantially higher than in the protiated formulation in which
all lipids contribute to this shift, but a lower temperature than
for the same transition in pure dCERNS. This indicates that a
Fig. 6 Peak positions of CH2 symmetric stretching and CD2 asymmetric stretching vibrations of FTIR spectra plotted as a function of temperature (0–90°C). (a)
Symmetric stretching vibrations of CH2 groups in native SC, regenerated SC, and regenerated SC on which Form
EOS, FormNS, or FormdNS was applied (b) The
CD2 asymmetric stretching vibrations of regenerated SC on which Form
dNS was applied.
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fraction of dFA and dCER NS interacts with protiated lipids,
but the dCER NS and dFA do not show a concerted order-
disorder transition with most of the protiated lipids. This may
demonstrate different structural domains in the formulation,
most probably FA-rich and CER-rich domains.
Incorporation of Lipids in Regenerated SC
After application of FormCOMBI on regenerating SC,
the CH2 rocking vibrations in the FTIR spectrum
showed two s t rong peaks a t around 719 and
730 cm−1, comparable to regenerated SC on which
FormEOS was applied (Fig. 8). No major differences
were observed after application of a formulation con-
taining dCER NS instead of CER NS. However, after
the use of dFA22 instead of FA22, the intensity of the
peak at 730 cm−1, relative to the intensity at 719 cm−1,
was decreased (Fig. 8d). This indicates that the FA22
from the formulation participates at least partly in the
orthorhombic packing with the protiated SC lipids.
The temperature dependence of the CH2 symmetric
stretching vibrations after application of the formula-
tions on regenerating SC was comparable to the tem-
perature dependence of regenerated SC without formu-
lation. When focusing on FormCOMBI(dNS), the onset of
transition of the CD2 asymmetric stretching vibrations
and CH2 symmetric stretching vibration after applica-
tion on SC is very similar, but the transition occurs
over a smaller temperature range in the CD2 asymmet-
ric stretching vibrations (compare Fig. 8e and f). This
temperature range is similar to that of the CD2
stretching vibrations in the formulation. However, the
thermotropic behavior of the CD2 asymmetric stretching
vibrations of FormCOMBI(dFA) shows a completely differ-
ent profile. The ordered-disordered transition starts at
around 26°C, as opposed to 16°C for the formulation
only, and the transition occurs in a very broad temper-
ature range. This indicates that at least a fraction of the
dFA from the formulation interacts with the SC lipids,
which show an ordered-disordered phase transition at
around 60–70°C. Furthermore, the contours of the
CD2 symmetric stretching vibrations indicate the pres-
ence of two vibration modes (see Supplementary Fig. 3)
with a main peak at a wavenumber of around
2090 cm−1 and a shoulder around 2086 cm−1.
Application of CER Containing Formulation Does Not
Influence Lamellar Lipid Organization
The lamellar organization in the lipid matrix was stud-
ied using SAXD. The peak positions are indicative for
the spacing of the lamellae in the SC. The diffraction
patterns of native and regenerated SC with or without
formulation are shown in Supplementary Fig. 4. All
SC samples showed a main peak at a q-position of
about 1.0 nm−1, which is attributed to the 1st order
SPP peak and the 2nd order LPP peak. In some sam-
ples, a small difference in shape of the peak was ob-
served, but the peak position was not changed.
Furthermore, sometimes a peak at q = 1.9 nm−1 was
Fig. 7 FTIR spectra showing CH2
rocking vibrations of lipids in
formulations as a function of
temperature (0–60°C) and peak
positions of CH2 symmetric
stretching and CD2 asymmetric
stretching vibrations of FTIR spectra
plotted as a function of temperature
(0–90°C). (a) FormCOMBI (only
protiated lipids), (b)
FormCOMBI(dNS) (dNS was used)
(c) FormCOMBI(dFA) (dFA22 was
used), (d) Symmetric stretching
vibrations of CH2 groups in
FormCOMBI (e) The CD2
asymmetric stretching vibrations of
FormCOMBI(dNS) and
Form.COMBI(dFA)
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observed, which corresponds to phase separated crys-
talline CHOL that is present in SC.
DISCUSSION
In the present study, the SkinBaR model that mimics several
aspects of the lipid organization in AD skin was used to inves-
tigate the effect of topical skin barrier repair formulations. We
demonstrate that after application of formulations containing
barrier lipids and one CER subclass, a higher fraction of SC
lipids adopts an orthorhombic lateral packing in the regener-
ated SC, mimicking more closely the lipid organization in
native human skin. However, when two CER subclasses were
combined with a FA, this effect was not observed.
In inflammatory skin diseases, like AD, the skin barrier
function is impaired as indicated by an increased TEWL
(23,24). Besides changes in protein levels in the epidermis in
these skin diseases, an altered lipid composition and organiza-
tion compared to healthy skin has also been reported
(13,23–31). Particularly the importance of the lipids for the
skin barrier has been indicated by a strong correlation be-
tween increased TEWL and reduced chain length of both
CER and FA, and a reduced fraction of lipids forming an
orthorhombic lateral packing (11,13,14). These results show
that the skin barrier might be improved by normalizing the
lipid composition and organization. Previously, several skin
barrier repair mixtures containing skin barrier lipids CER,
FA, and CHOL were reported (32–36). However, the precise
composition of the formulation is often not described (34–36).
Furthermore, most studies focus on TEWL and/or skin hy-
dration as end point measurements (32–34,36). None of these
studies investigated the effect of the formulations on the lipid
composition and/or organization in SC. This demonstrates
that little is known about the key interactions of the barrier
lipids applied in the formulations and the lipid matrix in the
SC, which may be an important underlying mechanism for
skin barrier repair. Therefore, additional research is needed to
provide detailed insights in these interactions and select the
optimal skin barrier repair formulation.
Previously, it has been reported that both natural
and synthetic VC applied on tape-stripped mouse skin
enhanced skin barrier repair in vivo (16,17). Based on
these findings, in the present study we developed formu-
lations containing the barrier lipids CER, FA, and
CHOL and examined their effect on the SC lipid
Fig. 8 FTIR spectra showing CH2 rocking vibrations of SC lipids after application of formulations as a function of temperature (0–60°C) and peak positions of CH2
symmetric stretching and CD2 asymmetric stretching vibrations of FTIR spectra plotted as a function of temperature (0–90°C). (a) Regenerated SC, (b)
Regenerated SC after application of FormCOMBI (only protiated lipids), (c) Regenerated SC after application of FormCOMBI(dNS), (d) Regenerated SC after
application of FormCOMBI(dFA), (e) Symmetric stretching vibrations of CH2 groups in regenerated SC after application of Form
COMBI (f) The CD2 asymmetric
stretching vibrations of regenerated SC after application of FormCOMBI(dNS) and Form.COMBI(dFA)
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organization in an ex vivo human skin barrier repair
(SkinBaR) model. This model mimics more closely the
morphology, the lipid organization, and the lipid com-
position of AD than that in mice skin: An increased
level of short chain CERs and a fraction of unsaturated
CERs are present in SC of the SkinBaR model, simi-
larly as in SC of AD skin (19,37).
In the present study, the CER containing formulation
was topically applied on regenerating SC of the SkinBaR
model in order to examine whether the lipid organization
could be normalized toward that in native human SC and
whether barrier lipids in the formulation participate in the
SC lipid matrix or mainly remain on the skin surface. In
order to examine this, FTIR studies were executed using
protiated and (if available) a deuterated CER or FA in the
formulations. The use of deuterated lipids in the formula-
tions applied on the SkinBaR model facilitates more de-
tailed analysis of the interactions between the deuterated
lipids from the formulations and the SC lipid matrix.
First, the effect of only one CER subclass in the formulation
was examined. Subsequently, a formulation with a single
FA in combination with the two CER subclasses was
studied.
Formulations
The physical stability of the formulations was exam-
ined during a period of 6 months. During the storage,
no crystals were observed. However, when CER NP or
CER EOP were introduced in the same formulation,
crystals were formed (results not shown). Therefore, all
experiments were performed using CER NS and CER
EOS.
CERs
Examination of the lateral lipid organization and conforma-
tional ordering of the lipids in the formulation indicated that
the presence of both the orthorhombic domains and the or-
dered phase start to disappear at around 10°C. To examine in
detail the interaction between CERs and the formulation
components, deuterated CER NS was used. Several observa-
tions suggest that dCER NS interacts with the other compo-
nents in the formulation, namely i) the CD2 stretching fre-
quencies show that the onset transition temperature to a fluid
phase is lower for dCER NS in FormdNS than that of pure
dCER NS, and ii) no crystals are observed in the formulation
during a period of 6 months. However, replacing CER NS by
dCER NS did not result in a decrease in the CH2 rocking
vibration contour at 730 cm−1. This suggests that dCER NS
does not participate in the orthorhombic lattice in the formu-
lation. As CER NS itself forms a hexagonal lateral packing, it
may be that CER NS is located in domains with a hexagonal
packing. Supplementation of CER EOS did increase the frac-
tion of lipids forming an orthorhombic packing and increases
the stability of the orthorhombic packing slightly. As no deu-
terated CER EOS is available, it could not be determined
whether CER EOS is intercalated in the orthorhombic
matrix.
FAs and CERs
In addition to the CERs, FA is another candidate barrier lipid
to incorporate in a formulation. In previous studies, FAs with
varying chain length were incorporated in the formulation
(21). FA22 showed the most abundant change toward a more
orthorhombic lateral packing and was therefore selected for
the present studies.
An important question to answer is whether a combination
of CER EOS and CER NS with FA22 in the formulation,
FormCOMBI, results in an increased fraction of lipids adopting
an orthorhombic packing. The results obtained from CH2
rocking vibrations in the FTIR spectra indicated an increased
fraction of lipids adopting an orthorhombic lateral packing
compared to a formulation with only one CER subclass or
FA (21). This is in accordance with previous results showing
that both CER EOS and (very) long chain FA are important
for the formation of orthorhombic domains (38–41).
To obtain more detailed information about the interaction
of CER and FA in the formulation, either CER NS or FA22
was replaced by its deuterated counterpart. Participation of at
least a fraction of both dCER NS and dFA22 in the ortho-
rhombic lattice in the formulation was demonstrated by the
reduced relative intensity of the rocking vibration peak located
at 730 cm−1 compared to the formulation with only protiated
lipids. Interaction of dFA with the other barrier components
in the formulation is further demonstrated by an increased
onset transition temperature of the CD2 stretching vibrations
in FormCOMBI(dFA) compared to that of only dFA in the for-
mulation and decreased compared to that of pure dFA
(21,22). However, a large difference in onset transition tem-
perature of dCER NS (FormCOMBI(dNS)) with dFA22
(FormCOMBI(dFA)) was observed. This strongly suggests that
at least two different types of domains of barrier lipids are
present in the formulation, most probably both containing
CERs as well as FAs, but the domains may be either dCER
NS rich (high order-disorder transition temperature) or dFA
rich domains (lower order-disorder transition temperature).
Interactions Between Formulations and Stratum
Corneum
After having characterized the formulations, we examined
the interactions of the formulations with the regenerating
SC. After application of FormEOS or FormNS on
regenerating SC, a higher fraction of lipids adopted an
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orthorhombic lateral packing as indicated by a higher rel-
ative intensity of the CH2 rocking peak at 730 cm
−1 in the
FTIR spectrum. The increase in intensity was more pro-
nounced with CER EOS than CER NS in the formulation,
most probably due to the long acyl chain of the former.
The increase in the 730 cm−1 relative intensity for
FormNS is only encountered when the FTIR spectrum in
the untreated regenerated SC does not exhibit a 730 cm−1
peak, demonstrating the presence of only a hexagonal lat-
eral packing. Based on the similar relative intensity of the
rocking vibrations after application of FormNS and
FormdNS there is no evidence that CER NS participates
in the orthorhombic packing of the SC lipid matrix.
Possibly CER NS participates in the hexagonal domains.
Therefore, we also examined the lipid ordering of the SC
lipid matrix after application of FormNS and FormdNS.
After application of both formulations on regenerating
SC, a comparable onset transition temperature was ob-
served. This onset transition temperature was also compa-
rable to that of FormdNS alone. However, there is a differ-
ence in temperature at which the ordered-disordered tran-
sition terminates, namely 62.2°C for FormdNS and 71.0°C
for regenerated SC treated with FormdNS. This indicates
that at least a part of the dCER NS interacts with lipids in
the SC matrix.
Finally, FormCOMBI was applied on regenerating SC and
analyzed in the same manner. Application of FormCOMBI, in
which CER EOS, CER NS, and FA22 are combined, did
not increase the fraction of lipids adopting an orthorhombic
lateral packing compared to untreated regenerated SC.
However, the absence of an increase in the formation of
the orthorhombic packing is probably due to the high frac-
tion of lipids forming an orthorhombic packing in the un-
treated regenerated SC, making it a bigger challenge to in-
crease the fraction of lipids forming an orthorhombic pack-
ing. The decreased relative intensity of the peak at 730 cm−1
after replacing FA22 by dFA22 in FormCOMBI indicates that
dFA22 participates in the orthorhombic lattice and is most
likely intercalated in the SC matrix. Previously, we have
reported the application of a formulation containing only
one FA (21). In that paper we show that dFA participate in
the orthorhombic lattice and that it interacts with the SC
lipid matrix (21). It seems that this effect has been slightly
reduced when CERs were added to the formulation.
Possibly, CER NS and CER EOS interfere with the inter-
action between FA and the SC lipid matrix probably by
stabilizing the FA in the formulation and reducing the
partitioning into the orthorhombic lipid matrix in the SC.
In contrast, the reduced peak intensity was not observed
when CER NS was replaced by dCER NS, suggesting that
CER NS is not intercalated in the orthorhombic domains in
the SC lipid matrix when FA22 and CER EOS are also
present in the formulation. From the stretching vibrations
there is also no evidence that CER NS is present in the SC
lipid matrix. However, as the ordered-disordered transition
of dCER NS in the formulation is in a similar temperature
range as that of the SC lipid matrix, some of the CER NS
may still intercalate in the hexagonal packing in the lipid
matrix, or CER NS may be present in the skin furrows and
may still influence barrier repair.
Several other formulations consisting of CERs, FA,
and CHOL report enhanced barrier repair for formula-
tions containing CER subclass NP (42–44). However,
mainly TEWL was used as skin barrier repair parame-
ter, and interaction with SC lipid matrix was not exam-
ined. In our formulation CER NP crystallizes and there-
fore CER NP was not suitable to be used in the present
study. Other studies report formulations in which CER
subclass AdS was used as CER component. Topical
application of these formulations resulted in decreased
TEWL values and a higher skin hydration after 4 weeks
(45,46). Furthermore, addition of CER AdS to the cul-
ture medium of reconstructed human skin resulted in
increased CER content, mainly caused by an increase
of CER EOS, NS, and NP (47).
CONCLUSION
In conclusion, we show that CERs interact with the
other components of a lipid formulation, resulting in a
higher fraction of lipids adopting an orthorhombic lat-
eral packing compared to a formulation without CERs.
These interactions were also observed for FA and CERs
when both lipid classes were present in the formulation.
After application of the formulation containing either
CER EOS or CER NS on regenerating SC of the
SkinBaR model, a denser lipid packing was observed,
suggesting that CERs from the formulation interact with
the SC lipid matrix. When studying a formulation with
the three barrier components FA, CER NS and CER
EOS, there is strong evidence that FA is interacting
with the orthorhombic domains in the SC lipid do-
mains, while there is no clear indication that CER NS
is intercalated within the SC lipid matrix.
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